Muscle and Nerve

Single-institutional reference values for concentric needle jitter analysis using the extrapolated reference values procedure: Comparison to published reference values.  63:113-116. 2021

Clinical features of LRP4/agrin-antibody–positive myasthenia gravis: A multicenter study.  62:333-343. 2020

Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.  62:261-266. 2020

Mouse genotyping in an hour.  61:679-680. 2020

Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease 2020

Metabolic syndrome and peripheral neuropathy 2020

Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.  60:707-715. 2019

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis.  60:700-706. 2019

Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.  60:14-24. 2019

Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.  59:201-207. 2019

Alterations in mitochondrial fission, fusion, and mitophagic protein expression in the gastrocnemius of mice after a sciatic nerve transection.  58:592-599. 2018

Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry.  58:90-98. 2018

Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies.  57:6-15. 2018

Quantification and characterization of grouped type I myofibers in human aging.  57:E52-E59. 2018

Subacute demyelinating polyradiculoneuropathy complicating Epstein–Barr virus infection in GATA2 haploinsufficiency.  57:150-156. 2018

International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.  54:1015-1022. 2016

Ocular LEMS or MLOS.  54:981-982. 2016

Comparisons of ultrasound-estimated intramuscular fat with fitness and health indicators.  54:743-749. 2016

Clinical spectrum of valosin containing protein (VCP)-opathy.  54:94-99. 2016

Acute myofascitis as a manifestation of chronic graft-versus-host disease.  53:327-329. 2016

Measurement of intramuscular fat by muscle echo intensity.  52:963-971. 2015

Changes in α7β1 integrin signaling after eccentric exercise in heat-shocked rat soleus.  51:562-568. 2015

Mechanosensitivity may be enhanced in skeletal muscles of spinal cord-injured versus able-bodied men.  50:599-601. 2014

Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?.  49:483-486. 2014

The role of chemokines in guillain-barré syndrome.  48:320-330. 2013

A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis.  48:76-84. 2013

Reply.  47:145-146. 2013

Psychometric evaluation of the myasthenia gravis composite using rasch analysis.  45:820-825. 2012

Recommendations for myasthenia gravis clinical trials.  45:909-917. 2012

Subacute brachial diplegia associated with west nile virus myelitis.  45:900-904. 2012

Re: Practice parameters in myasthenia gravis.  44:1001. 2011

Isolation and transcriptome analysis of adult zebrafish cells enriched for skeletal muscle progenitors.  43:741-750. 2011

Practice parameters and focusing research: Plasma exchange for myasthenia gravis.  43:625-626. 2011

Intraoperative on-nerve nerve conduction study and conversion factor in the sural nerve.  42:373-378. 2010

Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: Technical aspects and normative data.  41:850-856. 2010

3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS.  40:795-800. 2009

Racial differences in myasthenia gravis in Alabama.  39:328-332. 2009

Construction of an efficient evaluative instrument for myasthenia gravis: The MG composite.  38:1553-1562. 2008

Statins may aggravate myasthenia gravis.  38:1101-1107. 2008

Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis.  38:957-963. 2008

Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome.  35:178-183. 2007

Exercise-induced cramp, myoglobinuria, and tubular aggregates in phosphoglycerate mutase deficiency.  34:572-576. 2006

Electrodiagnostic criteria for carpal tunnel syndrome in axonal polyneuropathy.  33:747-752. 2006

Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.  33:500-504. 2006

Adult polyglucosan body disease: A case report of a manifesting heterozygote.  32:675-681. 2005

Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.  32:515-520. 2005

Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K⁺ channel antibodies.  27:757-760. 2003

Acute leg-cycling exercise attenuates the H-reflex recorded in soleus but not flexor carpi radialis.  28:609-614. 2003

Relation between in vivo and in vitro measurements of skeletal muscle oxidative metabolism.  24:1665-1676. 2001

Muscle metabolic economy is inversely related to exercise intensity and type II myofiber distribution.  24:654-661. 2001

Distal sensory nerve conduction of the superficial peroneal nerve: new method and its clinical application..  24:689-694. 2001

Distal sensory nerve conduction of the superficial peroneal nerve: New method and its clinical application.  24:689-694. 2001

Iatrogenic superior gluteal mononeuropathy.  21:1794-1796. 1998

Iatrogenic superior gluteal mononeuropathy..  21:1794-1796. 1998

Stiff-persons' syndrome associated with thymoma and subsequent myasthenia gravis.  20:493-498. 1997

Primary respiratory failure as the presenting symptom in Lambert–Eaton myasthenic syndrome.  16:712-715. 1993

A benign form of reducing body myopathy.  6:278-282. 1983

Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy.  6:312-316. 1983

Preparation of cell‐free extracellular matrix from human peripheral nerve.  5:335-344. 1982